Zheng Yueting, Stamminger Thomas, Hearing Patrick
Department of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.
Institute for Clinical and Molecular Virology, University of Erlangen-Nuremberg, Erlangen, Germany.
PLoS Pathog. 2016 Jan 25;12(1):e1005415. doi: 10.1371/journal.ppat.1005415. eCollection 2016 Jan.
Interferons (IFNs) are cytokines that have pleiotropic effects and play important roles in innate and adaptive immunity. IFNs have broad antiviral properties and function by different mechanisms. IFNs fail to inhibit wild-type Adenovirus (Ad) replication in established cancer cell lines. In this study, we analyzed the effects of IFNs on Ad replication in normal human cells. Our data demonstrate that both IFNα and IFNγ blocked wild-type Ad5 replication in primary human bronchial epithelial cells (NHBEC) and TERT-immortalized normal human diploid fibroblasts (HDF-TERT). IFNs inhibited the replication of divergent adenoviruses. The inhibition of Ad5 replication by IFNα and IFNγ is the consequence of repression of transcription of the E1A immediate early gene product. Both IFNα and IFNγ impede the association of the transactivator GABP with the E1A enhancer region during the early phase of infection. The repression of E1A expression by IFNs requires a conserved E2F binding site in the E1A enhancer, and IFNs increased the enrichment of the E2F-associated pocket proteins, Rb and p107, at the E1A enhancer in vivo. PD0332991 (Pabociclib), a specific CDK4/6 inhibitor, dephosphoryles pocket proteins to promote their interaction with E2Fs and inhibited wild-type Ad5 replication dependent on the conserved E2F binding site. Consistent with this result, expression of the small E1A oncoprotein, which abrogates E2F/pocket protein interactions, rescued Ad replication in the presence of IFNα or IFNγ. Finally, we established a persistent Ad infection model in vitro and demonstrated that IFNγ suppresses productive Ad replication in a manner dependent on the E2F binding site in the E1A enhancer. This is the first study that probes the molecular basis of persistent adenovirus infection and reveals a novel mechanism by which adenoviruses utilize IFN signaling to suppress lytic virus replication and to promote persistent infection.
干扰素(IFNs)是具有多效性的细胞因子,在固有免疫和适应性免疫中发挥重要作用。IFNs具有广泛的抗病毒特性,其作用机制各不相同。IFNs无法抑制已建立的癌细胞系中野生型腺病毒(Ad)的复制。在本研究中,我们分析了IFNs对正常人细胞中Ad复制的影响。我们的数据表明,IFNα和IFNγ均能阻断野生型Ad5在原代人支气管上皮细胞(NHBEC)和端粒酶逆转录酶永生化的正常人二倍体成纤维细胞(HDF-TERT)中的复制。IFNs抑制多种腺病毒的复制。IFNα和IFNγ对Ad5复制的抑制是E1A立即早期基因产物转录受抑制的结果。在感染早期,IFNα和IFNγ均会阻碍反式激活因子GABP与E1A增强子区域的结合。IFNs对E1A表达的抑制需要E1A增强子中一个保守的E2F结合位点,并且IFNs在体内增加了E2F相关口袋蛋白Rb和p107在E1A增强子处的富集。PD0332991(帕博西尼)是一种特异性CDK4/6抑制剂,可使口袋蛋白去磷酸化以促进其与E2Fs的相互作用,并抑制依赖于保守E2F结合位点的野生型Ad5复制。与该结果一致,小E1A癌蛋白的表达消除了E2F/口袋蛋白的相互作用,在存在IFNα或IFNγ的情况下挽救了Ad复制。最后,我们建立了体外持续性Ad感染模型,并证明IFNγ以依赖于E1A增强子中E2F结合位点的方式抑制Ad的有效复制。这是第一项探究持续性腺病毒感染分子基础的研究,并揭示了腺病毒利用IFN信号抑制裂解性病毒复制并促进持续性感染的新机制。